CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+8.31%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$5.17B
AUM Growth
+$5.17B
(+19%)
Cap. Flow
+$509M
Cap. Flow
% of AUM
9.85%
Top 10 Holdings %
Top 10 Hldgs %
16.85%
Holding
725
New
51
Increased
415
Reduced
155
Closed
32
Top Buys
| 1 |
CELG
Celgene Corp
CELG
|
$45.5M |
| 2 |
Gilead Sciences
GILD
|
$39.4M |
| 3 |
GE Aerospace
GE
|
$36.8M |
| 4 |
Motorola Solutions
MSI
|
$26M |
| 5 |
Regeneron Pharmaceuticals
REGN
|
$24.4M |
Top Sells
| 1 |
Johnson & Johnson
JNJ
|
$55.4M |
| 2 |
Amgen
AMGN
|
$30M |
| 3 |
MJN
Mead Johnson Nutrition Company
MJN
|
$23.3M |
| 4 |
Canadian National Railway
CNI
|
$21.7M |
| 5 |
Becton Dickinson
BDX
|
$18.5M |
Sector Composition
| 1 | Healthcare | 24.05% |
| 2 | Financials | 13.76% |
| 3 | Technology | 12.92% |
| 4 | Communication Services | 9.3% |
| 5 | Consumer Staples | 7.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Allstate
ALL
$53.9B
| $31.8M | 0.61% |
389,638
-1,574
| -0.4% | -$128K |
|
27
Philip Morris
PM
$254B
| $30.8M | 0.6% |
273,078
-44,765
| -14% | -$5.05M |
|
28
Berkshire Hathaway Class B
BRK.B
$1.08T
| $29.5M | 0.57% |
176,816
+32,359
| +22% | +$5.39M |
|
29
AbbVie
ABBV
$374B
| $29.4M | 0.57% |
450,934
+221,678
| +97% | +$14.4M |
|
30
Campbell Soup
CPB
$10.1B
| $28.3M | 0.55% |
493,583
+53,849
| +12% | +$3.08M |
|
31
Abbott
ABT
$230B
| $27.8M | 0.54% |
625,064
+196,395
| +46% | +$8.72M |
|
32
UnitedHealth
UNH
$279B
| $27.6M | 0.53% |
168,372
+21,943
| +15% | +$3.6M |
|
33
Citigroup
C
$175B
| $27.6M | 0.53% |
460,859
-9,399
| -2% | -$562K |
|
34
Travelers Companies
TRV
$62.3B
| $27.3M | 0.53% |
226,278
-5,396
| -2% | -$650K |
|
35
Wells Fargo
WFC
$258B
| $27M | 0.52% |
485,901
+64,742
| +15% | +$3.6M |
|
|
36
Motorola Solutions
MSI
$79B
| $26.8M | 0.52% |
310,699
+301,326
| +3,215% | +$26M |
|
37
Colgate-Palmolive
CL
$67.7B
| $25.4M | 0.49% |
347,505
+154,785
| +80% | +$11.3M |
|
38
Vertex Pharmaceuticals
VRTX
$102B
| $25.4M | 0.49% |
232,567
-24,851
| -10% | -$2.72M |
|
|
ALXN
39
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $25.4M | 0.49% |
209,397
+15,797
| +8% | +$1.92M |
|
40
Qualcomm
QCOM
$170B
| $23.7M | 0.46% |
413,309
+35,579
| +9% | +$2.04M |
|
41
Salesforce
CRM
$245B
| $23.7M | 0.46% |
285,982
+10,297
| +4% | +$853K |
|
42
Altria Group
MO
$112B
| $23.3M | 0.45% |
326,615
+119,574
| +58% | +$8.54M |
|
43
Chevron
CVX
$318B
| $22.5M | 0.44% |
209,983
-30,218
| -13% | -$3.24M |
|
44
Applied Materials
AMAT
$124B
| $22.5M | 0.44% |
578,129
-190,772
| -25% | -$7.42M |
|
45
Hartford Financial Services
HIG
$37.4B
| $22.2M | 0.43% |
461,867
+154,396
| +50% | +$7.42M |
|
46
Quest Diagnostics
DGX
$20.1B
| $21.8M | 0.42% |
221,601
+153,816
| +227% | +$15.1M |
|
47
Rockwell Automation
ROK
$38.1B
| $21.5M | 0.42% |
138,244
+126,122
| +1,040% | +$19.6M |
|
48
Unum
UNM
$12.4B
| $21.5M | 0.42% |
457,989
+149,488
| +48% | +$7.01M |
|
49
Schlumberger
SLB
$52.2B
| $21.4M | 0.41% |
273,890
+6,546
| +2% | +$511K |
|
|
DFS
50
DELISTED
Discover Financial Services
DFS
| $21.3M | 0.41% |
311,258
+54,212
| +21% | +$3.71M |
|